Prior Authorization Denials: The Fastest-Growing Problem in Healthcare

This is not a billing dispute. It is a permission slip your doctor must beg from your insurer before treating you, and the insurer increasingly says no. Practices now complete an average of 39 to 40 prior authorizations per physician per week. Physicians and their staff spend 13 hours a week — nearly two full business days — processing them, at an estimated cost of $34,000 per physician per year. Forty percent of physicians have staff who work exclusively on prior authorization. Ninety-four percent say it increases their burnout.

And the denials are accelerating. Seventy-four percent of physicians report that PA denials have increased over the last five years. Nearly a third say PAs are often or always denied.

The New Federal Data: Denial Rates by Program

For the first time, we can compare denial rates across the system, because CMS now requires insurers to publish them. KFF's August 2026 analysis of the first reporting cycle found insurers denied 12% of standard prior authorization requests in Medicare Advantage and 18% in ACA marketplace plans — roughly one in eight across the major government-subsidized programs.

The variation among individual insurers is the real story. In Medicare Advantage, denial rates ranged from 5% at Elevance to 17% at UnitedHealth Group. In Medicaid managed care, from 2% at L.A. Care Health Plan to 23% at Independence Health Group. In the ACA marketplace, from 3% at GuideWell to 25% at Centene. Same federal programs. Same rules. Wildly different answers to the same question: can this patient have this care?

Here's the figure the insurers least want you to see: when these denials are appealed, they get overturned at extraordinary rates — 67% in Medicare Advantage, 47% in Medicaid managed care, 43% in the ACA marketplace. Two out of three appealed MA denials were wrong, by the system's own later judgment. The prior authorization apparatus rejects first and reconsiders only when forced.

CMS-0057-F: The Rule That's Rewriting the Process

The federal government finally moved. CMS's Interoperability and Prior Authorization Final Rule — CMS-0057-F, published February 2024 — is the most significant federal intervention in prior authorization in decades, and its key provisions are now live.

As of January 1, 2026, impacted payers — Medicare Advantage organizations, Medicaid and CHIP programs, and marketplace plan issuers — must decide standard prior authorization requests within 7 calendar days and expedited requests within 72 hours. "Prior authorization is the only place in medicine where 'no' required no explanation — and the new rules finally make it explain itself." Generic denials are no longer acceptable: payers must provide a specific, actionable reason for every denial, the kind of rationale a provider can actually appeal or correct.

The transparency provisions hit in March 2026, when payers filed their first public reports of prior authorization metrics — approval rates, denial rates, average turnaround times. For the first time, a hospital negotiating a payer contract, or a patient choosing a plan, can see the numbers. The next milestone is January 1, 2027: four FHIR-based electronic prior authorization APIs must be operational, moving the process out of faxes and phone calls and into the EHR. The AMA is actively pressing CMS to hold that deadline against industry requests for enforcement discretion.

One gap to know: CMS-0057-F explicitly excludes drugs. Your insurer's pharmacy benefit still runs on its own timelines. A follow-on proposal, CMS-0062-P, would extend electronic PA requirements to drug decisions with a reported effective date of October 1, 2027 — but it remains a proposal, not law.

What's Actually Changing in 2026

Three shifts are converging. First, the 7-day/72-hour clocks are enforceable now, and the specific-reason requirement gives every denial a paper trail providers can work with. Second, public metrics mean denial rates are becoming a competitive and contractual variable — payers with 25% denial rates will have to explain themselves in negotiations and in the press. Third, the January 2027 API deadline, if held, attacks the 13-hours-a-week administrative burden at its root: integrated electronic workflows instead of payer portals and fax machines.

Skepticism is warranted — the AMA notes that a nearly identical 2018 industry pledge to streamline prior authorization produced little measurable change, and only a third of physicians believe the June 2025 pledge by roughly 60 commercial insurers will matter. Commercial employer plans, which cover most working Americans, aren't covered by CMS-0057-F at all, though at least 30 states have enacted or are developing their own requirements.

But the direction is unmistakable. Prior authorization is moving from an unmeasured, unexplained veto into a timed, reasoned, publicly reported decision. For patients, the practical advice hasn't changed: if your prior authorization is denied, appeal it. The data says the odds are better than you think.